SBI Securities’s AEON Biopharma AEON Stock Holding History

SBI Securities’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$167	Buy	232 +127	+121%	+$106	﹤0.01%	3374
2026 Q1	$103	Hold	105	–	–	﹤0.01%	3397
2025 Q4	$116	Sell	105 -1	-0.9%	-$1	﹤0.01%	3362
2025 Q3	$86	Hold	106	–	–	﹤0.01%	3558
2025 Q2	$81	Hold	106	–	–	﹤0.01%	3598
2025 Q1	$61	Buy	106 +105	+10,500%	+$748	﹤0.01%	3590
2024 Q4	$56	Buy	+1	New	+$58	﹤0.01%	3611

Other funds holding AEON

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

SBI Securities's AEON Position: Q2 2026 in Review

SBI Securities increased its AEON Biopharma (AEON) stake by 121% in Q2 2026, buying an estimated $106 and bringing the position to 232 shares worth $167. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

SBI Securities first reported a position in AEON in Q4 2024 and has held it in 7 quarters since. 5 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

SBI Securities held 232 shares of AEON Biopharma worth $167 as of Q2 2026.
SBI Securities bought 127 AEON Biopharma shares in Q2 2026, an estimated $106.
AEON Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3374 holding.
SBI Securities first reported a position in AEON Biopharma in Q4 2024 and has held it in 7 quarters since.
5 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.